Skip to content

To investigate the effect of ondansetron injection on the efficacy of norepinephrine in correcting hypotension after spinal anesthesia in cesarean section patients

To investigate the effect of ondansetron injection on the efficacy of norepinephrine in correcting hypotension after spinal anesthesia in cesarean section patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087883
Enrollment
Unknown
Registered
2024-08-06
Start date
2024-09-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-spinal supine hypotension in parturients

Interventions

Control group:Intravenous saline 2ml 10 min before anaesthesia in the control group
Experimental group:Intravenous ondansetron 4mg 10 min before anaesthesia in the experimental group

Sponsors

Hangzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1: Full-term singleton pregnancies (>=37 weeks) with an ASA classification of II or less were scheduled for elective caesarean section under intrathecal anaesthesia. 2: aged 20-40 years. 3: able to provide voluntary informed consent.

Exclusion criteria

Exclusion criteria: 1: Contraindications to intrathecal anaesthesia; 2: age 40 years; 3: hypersensitivity to norepinephrine or ondansetron; 4: pre-existing hypertension or hypertension in the current pregnancy, cardio-vascular disease; 5: long QT interval syndrome; 6: multiple pregnancies; 7: diabetes mellitus; 8: body weight 80 kg and height 175 cm; 9: significant coexisting maternal disorders, abruptio placenta, placenta praevia.

Design outcomes

Primary

MeasureTime frame
MEC90 of norepinephrine administered by intravenous pump for preventing post-spinal hypotension during cesarean delivery;

Secondary

MeasureTime frame
Remedial dose of norepinephrine;Number of occurrences of hypertension;Number of occurrences of hypotension;Number of occurrences of bradycardia;Remedial dose of atropine;Neonatal Apgar score;Umbilical cord blood PH;Nausea and vomiting and other adverse reactions;

Countries

China

Contacts

Public ContactJianliang Sun

Hangzhou First People's Hospital

sjl6805@zju.edu.cn+86 139 5806 9878

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026